ETFs

Silexion Granted Approval to Launch Human Trials That Could Redefine the Future of Cancer Treatment

WSW, NY, 24th March 2026, FinanceWire … Read More

Duke Robotics May Be Emerging as a Hidden Play on AI-Driven Grid Modernization Trends (OTCQB: DUKRD)

WSW, NY, 24th March 2026, FinanceWire … Read More

Entera May Be the 1st Winner of FDA’s New Framework Redefining the Multi Billion Dollar Osteoporosis Market

WSW, NY, 23rd March 2026, FinanceWire … Read More

Palatin’s Case Strengthens as Rhythm’s FDA Approval Validates Hypothalamic Obesity Market (PTN)

WSW, NY, 20th March 2026, FinanceWire … Read More

Purple Biotech Is Building What Could Be the Next Generation of Cancer Immunotherapy (NASDAQ: PPBT)

WSW, NY, 20th March 2026, FinanceWire … Read More

Duke Robotics Lands $1M+ Contract as Trump’s $1.9B Initiative Creates Tailwind Drone Innovator (OTCQB: DUKRD)

WSW, NY, 19th March 2026, FinanceWire … Read More

Nasus Pharma’s NS002 Demonstrates Consistent Early Advantage in Epinephrine Delivery (NYSE: NSRX)

WSW, NY, 19th March 2026, FinanceWire … Read More

PolyPid Approaches NDA Submission as New Medicare Model Creates Strong Incentives for SSI Prevention

WSW, NY, 18th March 2026, FinanceWire … Read More

Nasus Pharma’s Positive Phase 2 Data Validates the Speed and Reliability of the NS002 Powder Platform

WSW, NY, 16th March 2026, FinanceWire … Read More

Duke Robotics Could Be One of the Underdog Companies Emerging From Israel’s Drone Tech Boom (OTCQB: DUKRD)

WSW, NY, 12th March 2026, FinanceWire … Read More